Activx Biosciences, Inc.
- UEI
- LEPGJMYNCDE3
- CAGE
- 6DUX7
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- activx.com
- Founded
- 2000
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Kinase profiling services | National Institute on Drug Abuse | $179,600 | |
| Activx biosciences, INC.:1202352 [21-000971] | National Center for Advancing Translational Sciences | $12,800 | |
| Nichd - replacement award for 75N94020P00619 | National Institute of Child Health and Human Development | $10,850 | |
| Lats native kinase full panel profiling of 57 compounds. | National Institute on Drug Abuse | $148,200 | |
| Pots 19-042522 | National Cancer Institute | $24,990 |
About Activx Biosciences, Inc.
Activx Biosciences, Inc. is an emerging biopharmaceutical company that specializes in the discovery and development of drugs for major unmet medical needs, with a focus on hematology, oncology, metabolic, and infectious diseases. Through federal contract awards, Activx Biosciences provides professional services related to drug discovery and development, such as kinase profiling, native kinase profiling, and compound profiling services.
Specific services provided by Activx Biosciences under past federal contracts include kinase profiling services for the National Institutes of Health's National Center for Advancing Translational Sciences, with a completion date of November 2022 and potential value of $180,600. They also provided native kinase full panel profiling of 57 compounds for the National Institutes of Health's National Center for Advancing Translational Sciences in 2019, under a total small business set aside contract worth $148,200. Additional previous services include purchase orders for the National Institutes of Health's National Cancer Institute and National Institute of Child Health and Human Development, focused on areas aligned with the company's drug development specialties. Based on this contract history, Activx Biosciences supports federal agencies through providing specialized drug discovery and profiling services.
Quick answers
What is Activx Biosciences, Inc.'s UEI?
Activx Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is LEPGJMYNCDE3.
What is Activx Biosciences, Inc.'s CAGE code?
Activx Biosciences, Inc.'s CAGE code is 6DUX7.
What is Activx Biosciences, Inc.'s primary NAICS code?
Activx Biosciences, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Activx Biosciences, Inc. registered in SAM.gov?
Activx Biosciences, Inc.'s SAM.gov registration expired on August 3, 2023.
What is Activx Biosciences, Inc.'s most recent federal award?
Activx Biosciences, Inc.'s most recent federal contract award is Kinase profiling services (75N95022P00038), from National Institute on Drug Abuse, on November 30, 2021.
On GovTribe
See Activx Biosciences, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors